← Leaderboards

Sharon A. Savage

Cancer Epidemiology And Genetics

Google Scholar ↗PubMed ↗ORCID ↗

$0

Attributed

$0

Total exposure

0

Grants

0

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at Cancer Epidemiology And Genetics

Same institution · by research overlap

Mark H Greene$0
Jay Lubin$0

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsCancer RiskCollaborationsFamilyMutationSyndromeGenesMalignant Neoplasm Of OvaryGenome Wide Association StudyMalignant Breast NeoplasmCohortResearch PersonnelParticipantGerm-Line MutationPredispositionGenetic VariantEnrollmentGeneticEpidemiologyEtiologyMolecularPathogenesisPublishingFamily Member

Grant awards (65)

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$4,486,407

ZIA · FY2025 · CA · contact PI

Family Studies$4,359,428

ZIA · FY2025 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$541,094

ZIA · FY2025 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$392,042

ZIA · FY2025 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$122,491

ZIA · FY2025 · CA · contact PI

Pharmacogenetic Studies$39,630

ZIA · FY2025 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$4,956,360

ZIA · FY2024 · CA · contact PI

Family Studies$3,585,550

ZIA · FY2024 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$620,698

ZIA · FY2024 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$407,021

ZIA · FY2024 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$170,762

ZIA · FY2024 · CA · contact PI

Pharmacogenetic Studies$39,221

ZIA · FY2024 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$6,231,313

ZIA · FY2023 · CA · contact PI

Family Studies$3,991,206

ZIA · FY2023 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$734,066

ZIA · FY2023 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$584,764

ZIA · FY2023 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$245,466

ZIA · FY2023 · CA · contact PI

Pharmacogenetic Studies$105,048

ZIA · FY2023 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$5,497,964

ZIA · FY2022 · CA · contact PI

Family Studies$3,992,738

ZIA · FY2022 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection Supplemental$3,815,095

ZIA · FY2022 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$864,296

ZIA · FY2022 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$591,185

ZIA · FY2022 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$268,126

ZIA · FY2022 · CA · contact PI

Pharmacogenetic Studies$43,484

ZIA · FY2022 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$6,876,295

ZIA · FY2021 · CA · contact PI

Family Studies$3,391,730

ZIA · FY2021 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$607,373

ZIA · FY2021 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$544,689

ZIA · FY2021 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$175,286

ZIA · FY2021 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection Supplemental$102,212

ZIA · FY2021 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$11,528,656

ZIA · FY2020 · CA · contact PI

Family Studies$4,441,171

ZIA · FY2020 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection$867,010

ZIA · FY2020 · CA · contact PI

Epidemiology and Genetics of Susceptibility to COVID-19 Infection Supplemental funds$866,134

ZIA · FY2020 · CA · contact PI

Genetic Modifiers of Cancer Risk$632,364

ZIA · FY2020 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$607,873

ZIA · FY2020 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$250,610

ZIA · FY2020 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$6,601,269

ZIA · FY2019 · CA · contact PI

Family Studies$1,148,924

ZIA · FY2019 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$604,320

ZIA · FY2019 · CA · contact PI

Genetic Modifiers of Cancer Risk$473,552

ZIA · FY2019 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$335,353

ZIA · FY2019 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$719,464

ZIA · FY2018 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$432,958

ZIA · FY2018 · CA · contact PI

Genetic Modifiers of Cancer Risk$334,686

ZIA · FY2018 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$539,664

ZIA · FY2017 · CA · contact PI

Genetic Modifiers of Cancer Risk$445,441

ZIA · FY2017 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$332,906

ZIA · FY2017 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$9,672,204

ZIA · FY2016 · CA · contact PI

Genetic Modifiers of Cancer Risk$517,754

ZIA · FY2016 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$500,914

ZIA · FY2016 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$270,173

ZIA · FY2016 · CA · contact PI

Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$7,232,793

ZIA · FY2015 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$686,710

ZIA · FY2015 · CA · contact PI

Intervention Trials in Persons at Increased Genetic Risk of Cancer$459,731

ZIA · FY2015 · CA · contact PI

Genetic Modifiers of Cancer Risk$417,815

ZIA · FY2015 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$800,952

ZIA · FY2014 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$854,568

ZIA · FY2013 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$873,293

ZIA · FY2012 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$911,971

ZIA · FY2011 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$258,172

ZIA · FY2010 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$34,100

ZIA · FY2009 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology$23,141

Z01 · FY2008 · CA · contact PI

Genetic Epidemiology of Telomere Maintenance$0

Z01 · FY2006 · CP · contact PI